Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/353278/000162828019000875/novo-b20xf12x31x18.htm
August 2022
August 2022
July 2022
July 2022
July 2022
July 2022
July 2022
June 2022
June 2022
June 2022
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/353278/000162828019000875/novo-b20xf12x31x18.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Novo Nordisk A S.
Novo Nordisk A S's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Novo Nordisk A S provided additional information to their SEC Filing as exhibits
Ticker: NVO
CIK: 353278
Form Type: 20-F Annual Report
Accession Number: 0001628280-19-000875
Submitted to the SEC: Mon Feb 04 2019 1:30:58 PM EST
Accepted by the SEC: Mon Feb 04 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations